+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; By Product; Application; and Geography

  • ID: 4987836
  • Report
  • September 2020
  • Region: Global
  • 181 pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2021

FEATURED COMPANIES

  • BioFactura, Inc.
  • Corning Incorporated
  • GENERAL ELECTRIC
  • LakePharma, Inc.
  • Lonza
  • Merck KGaA
Hybridomas Segment to Register Highest CAGR in Cell Line Development Market during 2020-2027

According to this latest study on “Cell Line Development Market Forecast to 2027 - COVID-19 Impact and Analysis - by Type, Product, and Application,” the market was valued at US$ 4,160.42 million in 2019 and is projected to reach US$ 11,219.87 million by 2027; it is expected to grow at a CAGR of 13.3% from 2020 to 2027. The report highlights trends prevailing in the global cell line development market, and the drivers and restraints pertaining to the market growth.

The global cell line development market, based on type, is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell lines. The recombinant cell lines segment held the largest share of the market in 2019. This growth is ascribed to the increasing demand for recombinant cell lines in the production of therapeutic recombinant proteins. However, the hybridomas segment is estimated to register the highest CAGR during the forecast period. This growth is attributed to rising research and development activities for novel biologics.

Stable cell lines are widely used in a wide range application, including biologics production, drug screening, and gene functional studies. The COVID-19 pandemic led to disruptions in all phases of drug development, and it has compelled many pharmaceutical companies and clinical research organizations (CROs) to put their clinical studies on hold. The new government policies, stay-at-home orders, social distancing norms, and widespread anxiety are among the prime challenges faced by researchers conducting the ongoing studies.

The growth of the cell line development market is attributed to factors such as increasing adoption of regenerative medicines, rising prevalence of cancer in the world, and mounting investments in R&D by pharmaceutical and biotechnology companies. However, the risks associated with cell line contamination hinder the growth of this market. Merck KGaA, Thermo Fisher Scientific Inc., Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., and WuXiAppTec Group are among the leading companies operating in the global cell line development market.

The Report Segments Global Cell Line Development Market as Follows:

By Type
  • Primary Cell Line
  • Hybridomas
  • Continuous Cell Lines
  • Recombinant Cell Line
By Product
  • Equipment
  • Media & Reagent
By Application
  • Drug Discovery
  • Bioproduction
  • Tissue Engineering
By Geography

North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA
  • South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM
Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell line development market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global cell line development market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BioFactura, Inc.
  • Corning Incorporated
  • GENERAL ELECTRIC
  • LakePharma, Inc.
  • Lonza
  • Merck KGaA
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Cell Line Development Market - By Type
1.3.2 Global Cell Line Development Market - By Product
1.3.3 Global Cell Line Development Market - By Application
1.3.4 Global Cell Line Development Market - By Geography

2. Cell Line Development Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Cell Line Development - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Line Development Market in North America: PEST Analysis
4.2.2 Cell Line Development Market in Europe: PEST Analysis
4.2.3 Cell line development Market in APAC: PEST Analysis
4.2.4 Cell Line Development Market in MEA: PEST Analysis
4.2.5 Cell Line Development Market - South and Central America PEST Analysis
4.3 Expert Opinion

5. Global Cell Line Development Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Regenerative Medicines
5.1.2 Rising Prevalence of Cancer
5.1.3 Growing Investment in R&D by Pharmaceutical and Biotechnology Companies
5.2 Key Restraints
5.2.1 Risk Associated with Cell Line Contamination
5.3 Key Opportunity
5.3.1 Middle Income Countries Creating Development Opportunities
5.4 Future Trend
5.4.1 Consistent Research in Drug Discovery Activities
5.5 Impact Analysis

6. Cell Line Development Market - Global Analysis
6.1 Global Cell Line Development Market Revenue Forecast and Analysis
6.2 Global Cell Line Development Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1 Merck KGaA
6.3.2 Thermo Fisher Scientific Inc.

7. Cell Line Development Market - Revenue and Forecasts to 2027 - Type
7.1 Overview
7.2 Global Cell Line Development Market, by Type, 2019 & 2027 (% Share)
7.3 Primary Cell Line
7.3.1 Overview
7.3.2 Global Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Hybridomas
7.4.1 Overview
7.4.2 Global Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Continuous Cell Lines
7.5.1 Overview
7.5.2 Global Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Recombinant Cell Line
7.6.1 Overview
7.6.2 Global Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)

8. Cell Line Development Market Analysis and Forecasts to 2027 - Product
8.1 Overview
8.2 Global Cell Line Development Market, by Product, 2019 & 2027 (% Share)
8.3 Equipment
8.3.1 Overview
8.3.2 Global Equipment Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Media and Reagent
8.4.1 Overview
8.4.2 Global Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)

9. Cell Line Development Market Analysis and Forecasts to 2027 - Application
9.1 Overview
9.2 Global Cell Line Development Market Share by Application 2019 & 2027 (%)
9.3 Drug Discovery
9.3.1 Overview
9.3.2 Global Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Bioproduction
9.4.1 Overview
9.4.2 Global Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Tissue Engineering
9.5.1 Overview
9.5.2 Global Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)

10. Cell Line Development Market Revenue and Forecast to 2027 - Geographical Analysis
10.1 North America Cell Line Development Market, Revenue and Forecast to2027
10.1.1 Overview
10.1.2 North America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.3 North America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.4 North America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.5 North America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.6 North America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.1.7 US
10.1.7.1 US Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 US Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.7.3 US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.7.4 US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.8 Canada
10.1.8.1 Canada Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.8.3 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.8.4 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.9 Mexico
10.1.9.1 Mexico Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.9.3 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.9.4 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2 Europe Cell Line Development Market Revenue and Forecast to 2027
10.2.1 Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.2 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.3 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.4 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.5 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.2.6 Germany
10.2.6.1 Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.6.2 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.6.3 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.6.4 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.7 UK
10.2.7.1 UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.7.2 UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.7.3 UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.7.4 UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.8 France
10.2.8.1 France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.8.2 France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.8.3 France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.8.4 France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.9 Spain
10.2.9.1 Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.9.2 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.9.3 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.9.4 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.10 Italy
10.2.10.1 Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.10.2 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.10.3 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.10.4 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3 APAC Cell Line Development Market, Revenue and Forecast to 2027
10.3.1 Overview
10.3.2 APAC Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.3 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.4 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.5 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.6 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.3.7 China
10.3.7.1 China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.7.2 China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.7.3 China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.7.4 China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.8 Japan
10.3.8.1 Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.8.2 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.8.3 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.8.4 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.9 India
10.3.9.1 India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.9.2 India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.9.3 India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.9.4 India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.10 South Korea
10.3.10.1 South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.10.2 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.10.3 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.10.4 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.11 Australia
10.3.11.1 Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.11.2 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.11.3 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.11.4 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4 MEA Cell Line Development Market, Revenue and Forecast to 2027
10.4.1 Overview
10.4.2 MEA Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.3 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.4 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.5 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.6 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.4.7 UAE
10.4.7.1 UAE Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.7.2 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.7.3 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.7.4 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.8 Saudi Arabia
10.4.8.1 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.8.2 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.8.3 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.8.4 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.9 South Africa
10.4.9.1 South Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.9.2 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.9.3 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.9.4 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027
10.5.1 Overview
10.5.2 South and Central America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.3 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.4 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5.6 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.5.7 Brazil
10.5.7.1 Brazil Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.7.2 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.7.3 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.7.4 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5.8 Argentina
10.5.8.1 Argentina Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.8.2 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.8.3 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.8.4 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)

11. Impact Of COVID-19 Pandemic on Global Cell Line Development Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Cell Line Development Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in The Market, (%)
12.3 Organic Developments Done by The Companies in the Market
12.4 Inorganic Developments Done by The Companies in the Market

13. Cell Line Development Market- Key Company Profiles
13.1 Merck KGaA
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Information
13.2.4 Product /Services Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 SELEXIS
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product/Service Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioFactura, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 WuXi AppTec
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Service Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 LakePharma, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 General Electric
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lonza
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Information
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Corning Incorporated
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Note: Product cover images may vary from those shown
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Selexis SA (JSR Corporation)
  • BioFactura, Inc.
  • Corning Incorporated
  • Sartorius AG
  • Lonza
  • GENERAL ELECTRIC
  • LakePharma, Inc.
  • WuXi AppTec Group
Note: Product cover images may vary from those shown
Adroll
adroll